(Q45948485)

18 December 2017

title

Tissue distribution of the novel DPP-4 inhibitor BI 1356 is dominated by saturable binding to its target in rats. (English)

1 reference

18 December 2017

1 reference

Holger Fuchs

1

1 reference

18 December 2017

Rudolf Binder

series ordinal

2

1 reference

18 December 2017

Andreas Greischel

series ordinal

3

1 reference

18 December 2017

publication date

1 July 2009

1 reference

18 December 2017

Biopharmaceutics and Drug Disposition

published in

1 reference

18 December 2017

volume

30

1 reference

18 December 2017

issue

5

1 reference

18 December 2017

page(s)

229-240

1 reference

18 December 2017

Potent, orally bioavailable calcitonin gene-related peptide receptor antagonists for the treatment of migraine: discovery of N-[(3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1- (2,2,2-trifluoroethyl)azepan-3-yl]-4- (2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin

cites work

1 reference

Incretins and other peptides in the treatment of diabetes

21 January 2018

1 reference

21 January 2018

Cell-surface peptidases

1 reference

(R)-8-(3-amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione (BI 1356), a novel xanthine-based dipeptidyl peptidase 4 inhibitor, has a superior potency and longer duration of action compared wi

21 January 2018

1 reference

Crystal structure of human dipeptidyl peptidase IV/CD26 in complex with a substrate analog

21 January 2018

1 reference

Effect of renal insufficiency on the pharmacokinetics of sitagliptin, a dipeptidyl peptidase-4 inhibitor

21 January 2018

1 reference

An active-site mutation (Gly633-->Arg) of dipeptidyl peptidase IV causes its retention and rapid degradation in the endoplasmic reticulum

21 January 2018

1 reference

Dipeptidyl-peptidase IV (CD26)--role in the inactivation of regulatory peptides

21 January 2018

1 reference

Is the Fischer 344/CRJ rat a protein-knock-out model for dipeptidyl peptidase IV-mediated lung metastasis of breast cancer?

21 January 2018

1 reference

Pharmacokinetics, pharmacodynamics and tolerability of multiple oral doses of linagliptin, a dipeptidyl peptidase-4 inhibitor in male type 2 diabetes patients.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/BDD.662

1 reference

18 December 2017

1 reference

18 December 2017